0
     

Report Added
Report already added
Alzheimer's Disease Drug Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Alzheimer's Disease Drug Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026

Alzheimer's disease (AD), also referred to simply as Alzheimer's, is a chronic neurodegenerative disease that usually starts slowly and worsens over time. It is the cause of 60% to 70% of cases of dementia.

This report contains market size and forecasts of Alzheimer's Disease Drug in India, including the following market information:
India Alzheimer's Disease Drug Market Revenue, 2015-2020, 2021-2026, ($ millions)
India Alzheimer's Disease Drug Market Consumption, 2015-2020, 2021-2026, (M Units)
India Alzheimer's Disease Drug Production Capacity, 2015-2020, 2021-2026, (M Units)
Top Five Competitors in India Alzheimer's Disease Drug Market 2019 (%)
The global Alzheimer's Disease Drug market was valued at 2314.5 million in 2019 and is projected to reach US$ 1483.3 million by 2026, at a CAGR of -10.5% during the forecast period. While the Alzheimer's Disease Drug market size in India was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alzheimer's Disease Drug manufacturers, suppliers, distributors and industry experts on the impacts of the COVID-19 pandemic on businesses, with top challenges including ingredients and raw material delays, component and packaging shortages, reduced/cancelled orders from clients and consumers, and closures of production lines in some impacted areas.
This report also analyses and evaluates the COVID-19 impact on Alzheimer's Disease Drug production and consumption in India
Total Market by Segment:
India Alzheimer's Disease Drug Market, By Type, 2015-2020, 2021-2026 ($ millions) & (M Units)
India Alzheimer's Disease Drug Market Segment Percentages, By Type, 2019 (%)
Donepezil
Memantine
Rivastigmine

India Alzheimer's Disease Drug Market, By Application, 2015-2020, 2021-2026 ($ millions) & (M Units)
India Alzheimer's Disease Drug Market Segment Percentages, By Application, 2019 (%)
Early to Moderate Stages
Moderate to Severe Stages

Competitor Analysis
The report also provides analysis of leading market participants including:
Total Alzheimer's Disease Drug Market Competitors Revenues in India, by Players 2015-2020 (Estimated), ($ millions)
Total Alzheimer's Disease Drug Market Competitors Revenues Share in India, by Players 2019 (%)
Total India Alzheimer's Disease Drug Market Competitors Sales, by Players 2015-2020 (Estimated), (M Units)
Total India Alzheimer's Disease Drug Market Competitors Sales Market Share by Players 2019 ($ millions)
Further, the report presents profiles of competitors in the market, including the following:
Allergan
Eisai
Novartis
Daiichi Sankyo
Merz Pharma
Pfizer
Johnson & Johnson
1 Introduction to Research & Analysis Reports
1.1 Alzheimer's Disease Drug Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 India Alzheimer's Disease Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats

2 COVID-19 Impact: India Alzheimer's Disease Drug Overall Market Size
2.1 India Alzheimer's Disease Drug Market Size: 2020 VS 2026
2.2 India Alzheimer's Disease Drug Revenue, Prospects & Forecasts: 2015-2026
2.3 India Alzheimer's Disease Drug Sales (Consumption): 2015-2026

3 Company Landscape
3.1 Top Alzheimer's Disease Drug Players in India (including Foreign and Local Companies)
3.2 Top India Alzheimer's Disease Drug Companies Ranked by Revenue
3.3 India Alzheimer's Disease Drug Revenue by Companies (including Foreign and Local Companies)
3.4 India Alzheimer's Disease Drug Sales by Companies (including Foreign and Local Companies)
3.5 India Alzheimer's Disease Drug Price by Manufacturer (2015-2020)
3.6 Top 3 and Top 5 Alzheimer's Disease Drug Companies in India, by Revenue in 2019
3.7 India Manufacturers Alzheimer's Disease Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Alzheimer's Disease Drug Players in India
3.8.1 List of India Tier 1 Alzheimer's Disease Drug Companies
3.8.2 List of India Tier 2 and Tier 3 Alzheimer's Disease Drug Companies

4 Sights by Product
4.1 Overview
4.1.1 By Type - India Alzheimer's Disease Drug Market Size Markets, 2020 & 2026
4.1.2 Donepezil
4.1.3 Memantine
4.1.4 Rivastigmine
4.2 By Type - India Alzheimer's Disease Drug Revenue & Forecasts
4.2.1 By Type - India Alzheimer's Disease Drug Revenue, 2015-2020
4.2.2 By Type - India Alzheimer's Disease Drug Revenue, 2021-2026
4.2.3 By Type - India Alzheimer's Disease Drug Revenue Market Share, 2015-2026
4.3 By Type - India Alzheimer's Disease Drug Sales & Forecasts
4.3.1 By Type - India Alzheimer's Disease Drug Sales, 2015-2020
4.3.2 By Type - India Alzheimer's Disease Drug Sales, 2021-2026
4.3.3 By Type - India Alzheimer's Disease Drug Sales Market Share, 2015-2026
4.4 By Type - India Alzheimer's Disease Drug Price (Manufacturers Selling Prices), 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - India Alzheimer's Disease Drug Market Size, 2020 & 2026
5.1.2 Early to Moderate Stages
5.1.3 Moderate to Severe Stages
5.2 By Application - India Alzheimer's Disease Drug Revenue & Forecasts
5.2.1 By Application - India Alzheimer's Disease Drug Revenue, 2015-2020
5.2.2 By Application - India Alzheimer's Disease Drug Revenue, 2021-2026
5.2.3 By Application - India Alzheimer's Disease Drug Revenue Market Share, 2015-2026
5.3 By Application - India Alzheimer's Disease Drug Sales & Forecasts
5.3.1 By Application - India Alzheimer's Disease Drug Sales, 2015-2020
5.3.2 By Application - India Alzheimer's Disease Drug Sales, 2021-2026
5.3.3 By Application - India Alzheimer's Disease Drug Sales Market Share, 2015-2026
5.4 By Application - India Alzheimer's Disease Drug Price (Manufacturers Selling Prices), 2015-2026
6 Manufacturers & Brands Profiles
6.1 Allergan
6.1.1 Allergan Corporate Summary
6.1.2 Allergan Business Overview
6.1.3 Allergan Alzheimer's Disease Drug Major Product Offerings
6.1.4 Allergan Sales and Revenue in India (2015-2020)
6.1.5 Allergan Key News
6.2 Eisai
6.2.1 Eisai Corporate Summary
6.2.2 Eisai Business Overview
6.2.3 Eisai Alzheimer's Disease Drug Major Product Offerings
6.2.4 Eisai Sales and Revenue in India (2015-2020)
6.2.5 Eisai Key News
6.3 Novartis
6.3.1 Novartis Corporate Summary
6.3.2 Novartis Business Overview
6.3.3 Novartis Alzheimer's Disease Drug Major Product Offerings
6.3.4 Novartis Sales and Revenue in India (2015-2020)
6.3.5 Novartis Key News
6.4 Daiichi Sankyo
6.4.1 Daiichi Sankyo Corporate Summary
6.4.2 Daiichi Sankyo Business Overview
6.4.3 Daiichi Sankyo Alzheimer's Disease Drug Major Product Offerings
6.4.4 Daiichi Sankyo Sales and Revenue in India (2015-2020)
6.4.5 Daiichi Sankyo Key News
6.5 Merz Pharma
6.5.1 Merz Pharma Corporate Summary
6.5.2 Merz Pharma Business Overview
6.5.3 Merz Pharma Alzheimer's Disease Drug Major Product Offerings
6.5.4 Merz Pharma Sales and Revenue in India (2015-2020)
6.5.5 Merz Pharma Key News
6.6 Pfizer
6.6.1 Pfizer Corporate Summary
6.6.2 Pfizer Business Overview
6.6.3 Pfizer Alzheimer's Disease Drug Major Product Offerings
6.6.4 Pfizer Sales and Revenue in India (2015-2020)
6.6.5 Pfizer Key News
6.7 Johnson & Johnson
6.6.1 Johnson & Johnson Corporate Summary
6.6.2 Johnson & Johnson Business Overview
6.6.3 Johnson & Johnson Alzheimer's Disease Drug Major Product Offerings
6.4.4 Johnson & Johnson Sales and Revenue in India (2015-2020)
6.7.5 Johnson & Johnson Key News
6.8 Lundbeck
6.8.1 Lundbeck Corporate Summary
6.8.2 Lundbeck Business Overview
6.8.3 Lundbeck Alzheimer's Disease Drug Major Product Offerings
6.8.4 Lundbeck Sales and Revenue in India (2015-2020)
6.8.5 Lundbeck Key News

7 Alzheimer's Disease Drug Production Capacity, Export and Import Analysis
7.1 Alzheimer's Disease Drug Production Capacity and Value in India, Situation Analysis and Prediction, 2015-2026
7.1.1 India Alzheimer's Disease Drug Production Capacity, 2015-2026
7.1.2 India Alzheimer's Disease Drug Production 2015-2026
7.1.3 India Alzheimer's Disease Drug Production Value 2015-2026
7.2 Key Local Alzheimer's Disease Drug Manufacturers in India
7.2.1 India Key Local Alzheimer's Disease Drug Manufacturers Production Capacity
7.2.2 India Key Local Alzheimer's Disease Drug Manufacturers Production
7.2.3 India Key Local Alzheimer's Disease Drug Manufacturers Production Value
7.2.4 The Proportion of Alzheimer's Disease Drug Production Sold in India and Sold Other Than India by Manufacturers
7.3 Alzheimer's Disease Drug Export and Import in India
7.3.1 India Alzheimer's Disease Drug Export Market
7.3.2 India Alzheimer's Disease Drug Source of Imports

8 COVID-19 Impact: Key Market Trends, Opportunity, Drivers and Restraints
8.1 PESTLE Analysis for India Alzheimer's Disease Drug Market
8.2 Market Opportunities & Trends
8.3 Market Drivers
8.4 Market Restraints

9 COVID-19 Impact on Alzheimer's Disease Drug Supply Chain Analysis
9.1 Supply Chain Analysis
9.2 Upstream Market Analysis
9.3 Downstream and Clients Market Analysis
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Alzheimer's Disease Drug Distributors and Sales Agents in India

10 Conclusion

11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Disclaimer
List of Tables
Table 1. Key Players of Alzheimer's Disease Drug in India
Table 2. Top Players in India, Ranking by Revenue (2019)
Table 3. India Alzheimer's Disease Drug Revenue by Companies, (US$, Mn), 2015-2020
Table 4. India Alzheimer's Disease Drug Revenue Share by Companies, 2015-2020
Table 5. India Alzheimer's Disease Drug Sales by Companies, (M Units), 2015-2020
Table 6. India Alzheimer's Disease Drug Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Alzheimer's Disease Drug Price (2015-2020) (USD/Unit)
Table 8. India Manufacturers Alzheimer's Disease Drug Product Type
Table 9. List of India Tier 1 Alzheimer's Disease Drug Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of India Tier 2 and Tier 3 Alzheimer's Disease Drug Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Alzheimer's Disease Drug Revenue in India (US$, Mn), 2015-2020
Table 12. By Type - Alzheimer's Disease Drug Revenue in India (US$, Mn), 2021-2026
Table 13. By Type - Alzheimer's Disease Drug Sales in India (M Units), 2015-2020
Table 14. By Type - Alzheimer's Disease Drug Sales in India (M Units), 2021-2026
Table 15. By Application - Alzheimer's Disease Drug Revenue in India, (US$, Mn), 2015-2020
Table 16. By Application - Alzheimer's Disease Drug Revenue in India, (US$, Mn), 2021-2026
Table 17. By Application - Alzheimer's Disease Drug Sales in India, (M Units), 2015-2020
Table 18. By Application - Alzheimer's Disease Drug Sales in India, (M Units), 2021-2026
Table 19. Allergan Corporate Summary
Table 20. Allergan Alzheimer's Disease Drug Product Offerings
Table 21. Allergan Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 22. Eisai Corporate Summary
Table 23. Eisai Alzheimer's Disease Drug Product Offerings
Table 24. Eisai Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 25. Novartis Corporate Summary
Table 26. Novartis Alzheimer's Disease Drug Product Offerings
Table 27. Novartis Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 28. Daiichi Sankyo Corporate Summary
Table 29. Daiichi Sankyo Alzheimer's Disease Drug Product Offerings
Table 30. Daiichi Sankyo Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 31. Merz Pharma Corporate Summary
Table 32. Merz Pharma Alzheimer's Disease Drug Product Offerings
Table 33. Merz Pharma Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 34. Pfizer Corporate Summary
Table 35. Pfizer Alzheimer's Disease Drug Product Offerings
Table 36. Pfizer Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 37. Johnson & Johnson Corporate Summary
Table 38. Johnson & Johnson Alzheimer's Disease Drug Product Offerings
Table 39. Johnson & Johnson Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 40. Lundbeck Corporate Summary
Table 41. Lundbeck Alzheimer's Disease Drug Product Offerings
Table 42. Lundbeck Alzheimer's Disease Drug Sales (M Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2015-2020)
Table 43. Alzheimer's Disease Drug Production Capacity (M Units) of Local Manufacturers in India, 2015-2020
Table 44. Alzheimer's Disease Drug Production (M Units) of Local Manufacturers in India, 2015-2020
Table 45. India Alzheimer's Disease Drug Production Market Share of Local Manufacturers, 2015-2020
Table 46. Alzheimer's Disease Drug Production Value (US$, Mn) of Local Manufacturers in India, 2015-2020
Table 47. India Alzheimer's Disease Drug Production Value Market Share of Local Manufacturers, 2015-2020
Table 48. The Percentage of Alzheimer's Disease Drug Production Sold in India and Sold Other Than India by Manufacturers
Table 49. The Percentage of Alzheimer's Disease Drug Production Sold in India and Sold Other Than India by Manufacturers
Table 50. Dangeguojia Alzheimer's Disease Drug Sales (Consumption), Production, Export and Import, 2015-2020
Table 51. Raw Materials and Suppliers
Table 52. Alzheimer's Disease Drug Downstream Clients in India
Table 53. Alzheimer's Disease Drug Distributors and Sales Agents in India
List of Figures
Figure 1. Alzheimer's Disease Drug Segment by Type
Figure 2. Alzheimer's Disease Drug Segment by Application
Figure 3. Dangeguojia Alzheimer's Disease Drug Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Alzheimer's Disease Drug Market Size in India, (US$, Mn) & (M Units): 2020 VS 2026
Figure 6. India Alzheimer's Disease Drug Revenue, 2015-2026 (US$, Mn)
Figure 7. Alzheimer's Disease Drug Sales in India: 2015-2026 (M Units)
Figure 8. The Top 3 and 5 Players Market Share by Alzheimer's Disease Drug Revenue in 2019
Figure 9. By Type - India Alzheimer's Disease Drug Incremental Growth, (US$, Mn), 2015-2026
Figure 10. By Type - India Alzheimer's Disease Drug Market Share, 2015-2020
Figure 11. By Type - India Alzheimer's Disease Drug Market Share, 2020-2026
Figure 12. By Type - India Alzheimer's Disease Drug Price (USD/Unit), 2015-2026
Figure 13. By Application - Alzheimer's Disease Drug Revenue in India (US$, Mn), 2020 & 2026
Figure 14. By Application - India Alzheimer's Disease Drug Market Share, 2015-2020
Figure 15. By Application - India Alzheimer's Disease Drug Market Share, 2020-2026
Figure 16. By Application -India Alzheimer's Disease Drug Price (USD/Unit), 2015-2026
Figure 17. India Alzheimer's Disease Drug Production Capacity (M Units), 2015-2026
Figure 18. India Alzheimer's Disease Drug Actual Output (M Units), 2015-2026
Figure 19. India Alzheimer's Disease Drug Production Value (US$, Mn), 2015-2026
Figure 20. The Percentage of India Alzheimer's Disease Drug Export Destination, 2019
Figure 21. The Source of Imports of India Alzheimer's Disease Drug, 2019
Figure 22. PEST Analysis for India Alzheimer's Disease Drug Market in 2020
Figure 23. Alzheimer's Disease Drug Market Opportunities & Trends in India
Figure 24. Alzheimer's Disease Drug Market Drivers in India
Figure 25. Alzheimer's Disease Drug Market Restraints in India
Figure 26. Alzheimer's Disease Drug Industry Value Chain

Report Title: Alzheimer's Disease Drug Market in India - Manufacturing and Consumption, Outlook and Forecast 2020-2026


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW